TABLE 1. GLOBAL ANTIBODY DRUG CONJUGATES MARKET, BY DRUGS, 2016-2023 ($MILLION)
TABLE 2. ADCETRIS ANTIBODY DRUG CONJUGATES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. KADCYLA ANTIBODY DRUG CONJUGATES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL ANTIBODY DRUG CONJUGATES MARKET, BY MECHANISM OF ACTION, 2016-2023 ($MILLION)
TABLE 5. CD30 ANTIBODIES ANTIBODY DRUG CONJUGATES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 6. HER2 ANTIBODIES ANTIBODY DRUG CONJUGATES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL ANTIBODY DRUG CONJUGATES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 8. BREAST CANCER ANTIBODY DRUG CONJUGATES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. LYMPHOMA ANTIBODY DRUG CONJUGATES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA ANTIBODY DRUG CONJUGATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11. NORTH AMERICA ANTIBODY DRUG CONJUGATES MARKET, BY DRUGS, 2016-2023 ($MILLION)
TABLE 12. NORTH AMERICA ANTIBODY DRUG CONJUGATES MARKET, BY MECHANISM OF ACTION, 2016-2023 ($MILLION)
TABLE 13. NORTH AMERICA ANTIBODY DRUG CONJUGATES MARKET, BY APPLICATION 2016-2023 ($MILLION)
TABLE 14. EUROPE ANTIBODY DRUG CONJUGATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 15. EUROPE ANTIBODY DRUG CONJUGATES MARKET, BY DRUGS, 2016-2023 ($MILLION)
TABLE 16. EUROPE ANTIBODY DRUG CONJUGATES MARKET, BY MECHANISM OF ACTION, 2016-2023 ($MILLION)
TABLE 17. EUROPE ANTIBODY DRUG CONJUGATES MARKET, BY APPLICATION 2016-2023 ($MILLION)
TABLE 18. ASIA-PACIFIC ANTIBODY DRUG CONJUGATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 19. ASIA-PACIFIC ANTIBODY DRUG CONJUGATES MARKET, BY DRUGS, 2016-2023 ($MILLION)
TABLE 20. ASIA-PACIFIC ANTIBODY DRUG CONJUGATES MARKET, BY MECHANISM OF ACTION, 2016-2023 ($MILLION)
TABLE 21. ASIA-PACIFIC ANTIBODY DRUG CONJUGATES MARKET, BY APPLICATION 2016-2023 ($MILLION)
TABLE 22. LAMEA ANTIBODY DRUG CONJUGATES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. LAMEA ANTIBODY DRUG CONJUGATES MARKET, BY DRUGS, 2016-2023 ($MILLION)
TABLE 24. LAMEA ANTIBODY DRUG CONJUGATES MARKET, BY MECHANISM OF ACTION, 2016-2023 ($MILLION)
TABLE 25. LAMEA ANTIBODY DRUG CONJUGATES MARKET, BY APPLICATION 2016-2023 ($MILLION)
TABLE 26. PFIZER, INC.: COMPANY SNAPSHOT
TABLE 27. PFIZER, INC.: PRODUCT PORTFOLIO
TABLE 28. CELLDEX THERAPEUTICS INC: COMPANY SNAPSHOT
TABLE 29. CELLDEX THERAPEUTICS INC: PRODUCT PORTFOLIO
TABLE 30. SEATTLE GENETICS INC: COMPANY SNAPSHOT
TABLE 31. SEATTLE GENETICS INC: PRODUCT PORTFOLIO
TABLE 32. GENENTECH INC: COMPANY SNAPSHOT
TABLE 33. GENENTECH INC: PRODUCT PORTFOLIO
TABLE 34. IMMUNOGEN INC: COMPANY SNAPSHOT
TABLE 35. IMMUNOGEN INC: PRODUCT PORTFOLIO
TABLE 36. SANOFI S.A.: COMPANY SNAPSHOT
TABLE 37. SANOFI S.A.: PRODUCT PORTFOLIO
TABLE 38. IMMUNOMEDICS, INC: COMPANY SNAPSHOT
TABLE 39. IMMUNOMEDICS, INC: PRODUCT PORTFOLIO
TABLE 40. PROGENICS PHARMACEUTICALS INC.: COMPANY SNAPSHOT
TABLE 41. PROGENICS PHARMACEUTICALS INC.: PRODUCT PORTFOLIO
TABLE 42. BAYER HEALTHCARE PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 43. BAYER HEALTHCARE PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 44. SYNTHON HOLDING B.V.: COMPANY SNAPSHOT
TABLE 45. SYNTHON HOLDING B.V.: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 1. ANTIBODY DRUG CONJUGATES MARKET: MARKET SEGMENATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL DNA SEQUENCING MARKET, BY APPLICATION
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. TOP PLAYER POSITIONING: GLOBAL ANTIBODY DRUG CONJUGATES MARKET
FIGURE 7. PATENT ANALYSIS BY YEAR
FIGURE 8. PATENT ANALYSIS BY REGION
FIGURE 9. BARGAINING POWER OF BUYERS
FIGURE 10. BARGAINING POWER OF SUPPLIERS
FIGURE 11. THREAT OF NEW ENTRANTS
FIGURE 12. THREAT OF SUBSTITUTION
FIGURE 13. COMPETITIVE RIVALRY
FIGURE 14. ANTIBODY DRUG CONJUGATES MARKET: DRUGS SEGMENATION
FIGURE 15. ANTIBODY DRUG CONJUGATES MARKET: MECHANISM OF ACTION SEGMENATION
FIGURE 16. ANTIBODY DRUG CONJUGATES MARKET: BY APPLICATION SEGMENATION
FIGURE 17. U.S. ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 18. CANADA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 19. MEXICO ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 20. GERMANY ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 21. FRANCE ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 22. UK ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 23. ITALY ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 24. SPAIN ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 25. REST OF EUROPE ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 26. JAPAN ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 27. CHINA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 28. AUSTRALIA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 29. INDIA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 30. SOUTH KOREA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 31. TAIWAN ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 32. REST OF ASIA-PACIFIC ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 33. BRAZIL ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 34. TURKEY ANTIBODY DRUG CONJUGATES MARKET, 2016-20223 ($MILLION)
FIGURE 35. SAUDI ARABIA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 36. SOUTH AFRICA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)
FIGURE 37. REST OF LAMEA ANTIBODY DRUG CONJUGATES MARKET, 2016-2023 ($MILLION)